This study presents the synthesis, structural characterization, and biological assessment of a novel bis(N,N'-bis(benzylidene)-2-pyridinecarbohydrazide) molybdenum(VI) complex. The complex was synthesized via Schiff base condensation and characterized by FT-IR, UV-Vis, NMR, ESI-MS, and single-crystal X-ray diffraction. Computational studies, including molecular electrostatic potential (MEP), TD-DFT UV-Vis absorption, and HOMO-LUMO analysis, provided insights into electronic properties. Molecular docking, antimicrobial screening, and antioxidant assays revealed the potential pharmaceutical applications of the complex.
No takes yet. Share an insight, caveat, or question.
Lodhi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: